Innovation, Risk, and Patient Empowerment: The FDA-Mandated Withdrawal of 23andMe’s Personal Genome Service
Downing NS, Ross JS. Innovation, Risk, and Patient Empowerment: The FDA-Mandated Withdrawal of 23andMe’s Personal Genome Service. JAMA 2014, 311: 793-794. PMID: 24474248, DOI: 10.1001/jama.2014.148.Commentaries, Editorials and Letters